Fingerprint
Dive into the research topics of 'Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically